Febi-Rev 40 Tablet contains Febuxostat 40mg, a medication primarily used to manage hyperuricemia in patients with gout. Febuxostat is a xanthine oxidase inhibitor that works by reducing the production of uric acid in the body, thereby preventing gout attacks and the formation of uric acid crystals in joints. It is particularly beneficial for patients who are intolerant to or inadequately controlled by allopurinol. Febi-Rev 40 is typically prescribed for long-term use to maintain lower uric acid levels and reduce the risk of gout flare-ups. The tablet should be taken orally, usually once daily, with or without food, as directed by a healthcare professional. Patients are advised to maintain adequate hydration while on this medication to help prevent kidney stones. Common side effects may include nausea, joint pain, rash, or liver enzyme abnormalities, and any unusual symptoms should be reported to a doctor promptly. Febi-Rev 40 is contraindicated in patients with severe liver impairment or hypersensitivity to Febuxostat. Regular monitoring of uric acid levels and liver function tests is recommended during treatment to ensure safety and efficacy. This medication should be used under medical supervision to achieve optimal therapeutic outcomes.

Dosage & How to Use